Published on: 7/24/2025
Some people using GLP-1 medications may experience muscle loss, but the exact percentage is not clear.
Glucagon-like peptide-1 (GLP-1) medications are used to help with weight loss and managing blood sugar. Some studies suggest that these medications might cause a decrease in muscle mass, also known as lean body mass.
Research discusses changes in lean body mass with GLP-1 use, but often does not provide specific percentages of users experiencing muscle loss. Studies examining the effects of GLP-1 receptor agonists also do not always specify how many people lose muscle. Reviews of the impact of specific GLP-1 medications, like semaglutide, on lean mass typically do not give a precise percentage of muscle loss.
While these references discuss the potential for muscle loss with GLP-1 medications, they do not specify how many people are affected. If you are using these medications and have concerns about muscle loss, it might be helpful to discuss this with your healthcare provider.
(References)
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.